Education
About Us
Working with TipRanks
Follow Us
Tivic Health Systems (TIVC)
NASDAQ:TIVC
Earnings Data
Report Date
May 19, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-1.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 21, 2025
|% Change Since: -1.41%
|Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Neutral
Tivic Health Systems is undergoing a significant transformation with the acquisition of a promising drug candidate and strategic shift towards diversified therapeutics. The company shows potential for future growth and regulatory approvals despite current financial challenges, such as decreased revenue and gross profit.Company Guidance
In the call, Tivic Health Systems provided extensive guidance on its strategic transformation and financial performance for the year 2024, with a strong focus on 2025 initiatives. Key metrics included a revenue of $0.8 million, down from $1.2 million in 2023, primarily due to a 41% decrease in unit sales. The company reported a net loss reduction to $5.7 million from $8.2 million in the previous year. Tivic Health Systems announced the acquisition of worldwide exclusive rights to Intellimod, a phase three immunomodulatory drug candidate, with over $140 million invested in its development. The plan is to move into manufacturing validation for Intellimod, with expectations of FDA approval potentially leading to market availability in two years. Additionally, the company is advancing its noninvasive vagus nerve stimulation program and has secured a $25 million equity line of credit to support these initiatives. With no debt, $2 million in cash and equivalents, and a recent reverse stock split, Tivic Health Systems aims to strengthen its position in the biopharmaceutical sector and achieve compliance with NASDAQ listing requirements.Acquisition of Immunomodulatory Drug Candidate
Tivic Health Systems acquired worldwide exclusive rights to a phase three immunomodulatory drug candidate, Intellimod, from Staterra Biopharma, with rights to five additional indications and a second molecular structure, Entelasta. Over $140 million has been invested in development, and the drug aims to treat acute radiation syndrome (ARS), boasting a 3x increase in survival rates in animal models.
Strategic Transformation into a Diversified Therapeutics Company
The company is transitioning into a diversified therapeutic company with a robust pipeline combining biologic and bioelectronic medicine to focus on immune dysrhythmias, supported by the addition of former Staterra Biopharma CEO Michael K. Hanley as Chief Operating Officer.
Progress in Vagus Nerve Stimulation (VNS) Program
Tivic Health Systems is developing a noninvasive cervical vagus nerve stimulation device, showing a 400% increase in effects with personalized stimulation. This device aims to treat conditions like inflammatory, cardiac, and neurologic disorders without invasive surgeries.
NASDAQ Compliance and Financial Flexibility
The company expects to regain NASDAQ compliance with continued listing requirements and secured a $25 million equity line of credit to fund stages of development, potentially fully funding Intellimod's commercialization.
---
TIVC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TIVC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 21, 2025 | $3.55 | $3.41 | -3.94% |
| Nov 15, 2024 | $6.24 | $4.92 | -21.15% |
| Aug 14, 2024 | $5.30 | $4.93 | -6.98% |
| May 15, 2024 | $8.56 | $8.24 | -3.74% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Tivic Health Systems (TIVC) report earnings?
Tivic Health Systems (TIVC) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
What is Tivic Health Systems (TIVC) earnings time?
Tivic Health Systems (TIVC) earnings time is at May 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TIVC EPS forecast?
Currently, no data Available
---